María C. Leiva

983 total citations
24 papers, 729 citations indexed

About

María C. Leiva is a scholar working on Oncology, Biomedical Engineering and Surgery. According to data from OpenAlex, María C. Leiva has authored 24 papers receiving a total of 729 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 7 papers in Biomedical Engineering and 5 papers in Surgery. Recurrent topics in María C. Leiva's work include Cancer Cells and Metastasis (5 papers), 3D Printing in Biomedical Research (5 papers) and Nanoparticle-Based Drug Delivery (4 papers). María C. Leiva is often cited by papers focused on Cancer Cells and Metastasis (5 papers), 3D Printing in Biomedical Research (5 papers) and Nanoparticle-Based Drug Delivery (4 papers). María C. Leiva collaborates with scholars based in United States, Spain and Sweden. María C. Leiva's co-authors include C. Richard Lyttle, Robert E. Handschumacher, Steven Fischkoff, Qing Xu, Lisa A. Hasty, José Prados, Göran Landberg, Anders Ståhlberg, Elena Garré and Cindy T. McEvoy and has published in prestigious journals such as JAMA, Journal of Biological Chemistry and Scientific Reports.

In The Last Decade

María C. Leiva

23 papers receiving 720 citations

Peers

María C. Leiva
C. Luyten Belgium
Asghar Ali United States
Y. Wang United States
María C. Leiva
Citations per year, relative to María C. Leiva María C. Leiva (= 1×) peers Yunchun Zhao

Countries citing papers authored by María C. Leiva

Since Specialization
Citations

This map shows the geographic impact of María C. Leiva's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by María C. Leiva with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites María C. Leiva more than expected).

Fields of papers citing papers by María C. Leiva

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by María C. Leiva. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by María C. Leiva. The network helps show where María C. Leiva may publish in the future.

Co-authorship network of co-authors of María C. Leiva

This figure shows the co-authorship network connecting the top 25 collaborators of María C. Leiva. A scholar is included among the top collaborators of María C. Leiva based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with María C. Leiva. María C. Leiva is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Leiva, María C., Elena Garré, Anders Ståhlberg, et al.. (2023). Patient-derived scaffolds representing breast cancer microenvironments influence chemotherapy responses in adapted cancer cells consistent with clinical features. Journal of Translational Medicine. 21(1). 924–924. 4 indexed citations
2.
Garré, Elena, et al.. (2021). Patient-derived scaffolds as a drug-testing platform for endocrine therapies in breast cancer. Scientific Reports. 11(1). 13334–13334. 23 indexed citations
3.
Leiva, María C., Pernilla Gregersson, Mattias Berglin, et al.. (2021). Optimized alginate-based 3D printed scaffolds as a model of patient derived breast cancer microenvironments in drug discovery. Biomedical Materials. 16(4). 45046–45046. 20 indexed citations
4.
Leiva, María C., Elena Garré, Yalda Bogestål, et al.. (2020). Breast cancer patient‐derived scaffolds as a tool to monitor chemotherapy responses in human tumor microenvironments. Journal of Cellular Physiology. 236(6). 4709–4724. 29 indexed citations
5.
Gaspar, Diana P., María C. Leiva, Lídia Gonçalves, et al.. (2019). Transfection of Pulmonary Cells by Stable pDNA -Polycationic Hybrid Nanostructured Particles. Nanomedicine. 14(4). 407–429. 18 indexed citations
6.
Leiva, María C., Raúl Ortíz, Rafael Contreras‐Cáceres, et al.. (2017). Tripalmitin nanoparticle formulations significantly enhance paclitaxel antitumor activity against breast and lung cancer cells in vitro. Scientific Reports. 7(1). 13506–13506. 29 indexed citations
7.
Contreras‐Cáceres, Rafael, María C. Leiva, Raúl Ortíz, et al.. (2017). Paclitaxel-loaded hollow-poly(4-vinylpyridine) nanoparticles enhance drug chemotherapeutic efficacy in lung and breast cancer cell lines. Nano Research. 10(3). 856–875. 22 indexed citations
8.
Rama, Ana R., Laura Cabeza, Cristina Jiménez‐Luna, et al.. (2016). Last Advances in Nanocarriers-Based Drug Delivery Systems for Colorectal Cancer. Current Drug Delivery. 13(6). 830–838. 17 indexed citations
9.
Ortíz, Raúl, et al.. (2016). Nanomedical Platform for Drug Delivery in Cancer. Current Organic Chemistry. 21(23). 7 indexed citations
10.
Martín‐Banderas, Lucía, José Prados, José Manuel Calderón‐Montaño, et al.. (2015). In vitro and in vivo evaluation of Δ9-tetrahidrocannabinol/PLGA nanoparticles for cancer chemotherapy. International Journal of Pharmaceutics. 487(1-2). 205–212. 43 indexed citations
11.
McEvoy, Cindy T., Diane Schilling, Keith E. Jackson, et al.. (2014). Vitamin C Supplementation for Pregnant Smoking Women and Pulmonary Function in Their Newborn Infants. JAMA. 311(20). 2074–2074. 137 indexed citations
12.
Prados, José, Consolación Melguizo, Gloria Perazzoli, et al.. (2013). Application of Nanotechnology in the Treatment and Diagnosis of Gastrointestinal Cancers: Review of Recent Patents. Recent Patents on Anti-Cancer Drug Discovery. 9(1). 21–34. 10 indexed citations
13.
Pérez, María Claudia, Peter V.N. Bodine, María C. Leiva, Keith Isaacson, & Barry S. Komm. (2002). Signal transduction pathways involved in macrophage migration induced by peritoneal fluid chemotactic factors in stages I and II endometriosis. Fertility and Sterility. 77(6). 1261–1268. 5 indexed citations
14.
Leiva, María C., et al.. (1999). Fetal cardiac development and hemodynamics in the first trimester. Ultrasound in Obstetrics and Gynecology. 14(3). 169–174. 60 indexed citations
15.
Leiva, María C., Lisa A. Hasty, & C. Richard Lyttle. (1994). Inflammatory changes of the endometrium in patients with minimal-to-moderate endometriosis. Fertility and Sterility. 62(5). 967–972. 25 indexed citations
16.
Leiva, María C., Lisa A. Hasty, Samantha M. Pfeifer, Luigi Mastroianni, & C. Richard Lyttle. (1993). Increased chemotactic activity of peritoneal fluid in patients with endometriosis. American Journal of Obstetrics and Gynecology. 168(2). 592–598. 45 indexed citations
17.
Leiva, María C. & C. Richard Lyttle. (1992). Leukocyte chemotactic activity of FKBP and inhibition by FK506. Biochemical and Biophysical Research Communications. 186(2). 1178–1183. 22 indexed citations
18.
Xu, Qing, María C. Leiva, Steven Fischkoff, Robert E. Handschumacher, & C. Richard Lyttle. (1992). Leukocyte chemotactic activity of cyclophilin.. Journal of Biological Chemistry. 267(17). 11968–11971. 167 indexed citations
19.
Leiva, María C., C. Richard Lyttle, & Peter H. Jellinck. (1991). Complement C3 synthesis, peroxidase activity and eosinophil chemotaxis in the rat uterus: Effect of estradiol and testosterone. Molecular and Cellular Endocrinology. 81(1-3). 105–111. 12 indexed citations
20.
Leiva, María C., et al.. (1991). Ontogeny of the Production of an Estrogen-Regulated Eosinophil Chemotactic Factor in the Rat Uterus1. Biology of Reproduction. 45(6). 818–823. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026